Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW043FAIntroduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Central Vein, Percutaneous Approach, New Technology Group 10

✓ Valid for 2027Non-O.R. procedure

Short description: Introduce Non-CAR-T Ther in Central Vein, Perc, New Tech 10

Code last changed in FY2025 (effective October 1, 2024). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW043FA

XW043FA is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with non-chimeric antigen receptor t-cell immune effector cell therapy (qualifier: new technology group 10). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW033FA (peripheral vein).

With a different device, use XW0433A (maribavir anti-infective), XW0434A (stem cells, somatic), XW0435A (ifezuntirgene inilparvovec), XW0438A (mineral-based topical hemostatic agent), XW0439A (odronextamab antineoplastic), XW043BA (vancomycin-eluting bone void filler) and 3 more.

It is a non-O.R. procedure that is part of the MS-DRG logic for DRG 018 (Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies), under the surgical category “Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies”.

It was added in FY2025, effective October 1, 2024.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
4Central Vein
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
FNon-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy

Includes: T-cell Antigen Coupler T-cell (TAC-T) Therapy; T-cell Receptor-Engineered T-cell (TCR-T) Therapy; Tumor-Infiltrating Lymphocyte (TIL) Therapy

7. Qualifier
ANew Technology Group 10

Other versions of this procedure

Different body part

MS-DRG v44.0 grouping

All DRGs →

Surgical MS-DRGs this procedure can group to, depending on the principal diagnosis's MDC.

MDC PRE · Pre-MDC · Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2025 (effective 10/1/2024): Added
  • No changes since FY2025.

Common questions about XW043FA

Is XW043FA a valid ICD-10-PCS code for 2027?

Yes. XW043FA is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

Is XW043FA an O.R. procedure?

No. XW043FA is designated non-O.R. in MS-DRG v44.0.

What DRG does XW043FA group to?

Depending on the principal diagnosis, XW043FA can group to MS-DRG 018.